FDA approves Alzheimer’s treatment Leqembi, clearing the way for Medicare coverage
The U.S. Food and Drug Administration on Thursday granted full approval to the Biogen BIIB and Eisai Co. Ltd. ESALF Alzheimer’s treatment Leqembi, a step that secures Medicare…
Read more FDA approves Alzheimer’s treatment Leqembi, clearing the way for Medicare coverage